Proscia has received a CE Mark for its Concentriq Dx solution for use in primary diagnosis. With this certification, Proscia accelerates its entry into the diagnostic pathology market in Europe and other key geographies globally to help laboratories keep pace with the rising cancer burden. Read more here:
New to digital pathology? Learn how whole slide imaging is changing the industry here.